Treating Major Depression With Yoga Mono-therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
18 years of age or older
Able to give voluntary, informed consent
English-speaking
Diagnosis of clinical depression
Current use of antidepressant medication
Current engagement in psychotherapy
Current pregnancy
Significant medical issues interfering with yoga practice